highperformr logo

Takeda's Overview

Total employees36753
HeadquartersTokyo
Founded1781

Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. Takeda is committed to discovering and delivering life-transforming treatments, guided by its commitment to patients, its people, and the planet. The company focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). Takeda also makes targeted R&D investments in Plasma-Derived Therapies and Vaccines. Takeda aims to bring Better Health and a Brighter Future to people worldwide by translating science into highly innovative medicines.

Where is Takeda's Headquarters?

Takeda officeTakeda officeTakeda officeTakeda office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the global corporate headquarters, overseeing worldwide operations, strategic planning, research and development direction, and corporate governance for the entire Takeda group.

Notable Features:

The Takeda Global Headquarters building, completed in 2018, is a state-of-the-art, sustainable facility designed to promote collaboration and innovation. It features open-plan workspaces, advanced communication technologies, and employee wellness amenities.

Work Culture:

Takeda's Tokyo HQ fosters a work culture rooted in 'Takeda-ism' (Integrity, Fairness, Honesty, Perseverance) and patient-centricity. It promotes collaboration, innovation, and continuous learning, supported by modern facilities designed for employee well-being and flexible work styles. There's a strong emphasis on diversity, equity, and inclusion.

HQ Significance:

The Tokyo Global Headquarters is a symbol of Takeda's long heritage in Japan and its position as a leading global biopharmaceutical company. It serves as the nerve center for strategic decision-making, R&D oversight, and global business operations, connecting its worldwide network.

Values Reflected in HQ: The headquarters' design reflects Takeda's core values: patient-centricity, innovation, collaboration, sustainability, and a commitment to its people and the communities it serves.

Location:

Takeda operates in approximately 80 countries and regions worldwide, with a significant presence in Japan, the United States, Europe, Latin America, Africa, the Middle East, and Asia. Its global functions include extensive research and development facilities, a network of manufacturing plants, comprehensive commercial operations (sales, marketing, and distribution), and various corporate support services, all dedicated to addressing unmet medical needs globally.

Street Address:

1-1, Nihonbashi-Honcho 2-chome, Chuo-ku

City:

Tokyo

State/Province:

Tokyo

Country:

Japan

Takeda's Global Presence

Lexington, Massachusetts, USA

Address: 95 Hayden Avenue, Lexington, MA 02421, USA

Manages and executes Takeda's strategy within the U.S. pharmaceutical market, focusing on delivering innovative medicines to American patients, engaging with healthcare providers and institutions, and navigating the U.S. regulatory and reimbursement landscape.

Buying Intent Signals for Takeda

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Takeda

As of April 2025, Takeda' leadership includes:

Christophe Weber - Representative Director, President and Chief Executive Officer
Andrew S. Plump, M.D., Ph.D. - President, Research & Development
Costa Saroukos - Chief Financial Officer
Ramona Sequeira - President, Global Portfolio Division
Julie Kim - President, U.S. Business Unit and U.S. Country Head
Gabriele Ricci - Chief Data & Technology Officer
P.J. Haley - Chief Corporate Affairs Officer
Stephen W. L. Sublett - Chief Human Resources Officer

Investors of Takeda

Takeda has been backed by several prominent investors over the years, including:

BlackRock Japan Co., Ltd.
The Vanguard Group, Inc.
Nikko Asset Management Co., Ltd.
Sumitomo Mitsui Trust Asset Management Company, Limited
Nomura Asset Management Co., Ltd.

Executive New Hires/Exits in the Last 12 Months

Hire3
Exits0

Takeda has actively shaped its leadership over the past 12 months (approx. May 2023 - May 2024), notably appointing new executives to spearhead its data & technology, corporate affairs, and human resources functions. These strategic hires underscore the company's focus on digital transformation, stakeholder engagement, and talent development to drive future growth. No major C-suite departures were prominently announced during this period.

New Appointments:

Gabriele Ricci, Gabriele Ricci appointed as Takeda's Chief Data & Technology Officer to lead digital transformation and enhance data capabilities.
P.J. Haley, P.J. Haley appointed to lead global corporate affairs, including communications and public affairs.
Stephen W. L. Sublett, Stephen Sublett appointed to lead Takeda's global human resources strategy and operations.

Technology (Tech Stack) used by Takeda

Discover the tools Takeda uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Takeda Email Formats and Examples

Takeda Pharmaceutical primarily uses the 'firstname.lastname@takeda.com' email format for its employees. Variations might exist but this is the most common one.

firstname.lastname@takeda.com

Format

jane.doe@takeda.com

Example

85%

Success rate

News and media

takeda.comMay 9, 2024

Takeda Pharmaceutical news title: Takeda Delivers Resilient Full Year FY2023 Results Amidst LOE Impacts; Strong Core Growth Expected to Drive Return to Growth in FY2024

Takeda announced its financial results for the full fiscal year 2023, highlighting resilience despite loss of exclusivity impacts. The company reported strong core revenue growth and outlined expectations for a return to overall growth in fiscal year 2024, driven by its Growth and Launch Products....more

takeda.comApril 26, 2024

Takeda Pharmaceutical news title: Takeda Receives Positive CHMP Opinion for Fruzaqla™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorization for Fruzaqla (fruquintinib) for adult patients with previously treated metastatic colorectal cancer (mCRC)....more

takeda.comFebruary 29, 2024

Takeda Pharmaceutical news title: Takeda Announces Phase 3 ADMIRE-CD II Study of Alofisel® (darvadstrocel) Did Not Meet Its Primary Endpoint

Takeda announced that the Phase 3 ADMIRE-CD II study evaluating Alofisel (darvadstrocel) for the treatment of complex Crohn's perianal fistulas (CPF) did not meet its primary endpoint of combined remission at 24 weeks. The safety profile was consistent with previous studies....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Takeda, are just a search away.